The Proliferative Response of CD4 T Cells to Steady-state CD8+ Dendritic Cells is Restricted by Post-activation Death
Overview
Affiliations
CD8(+) splenic dendritic cells (DCs) from steady-state mice are less effective than the CD8(-) DC subset in their capacity to stimulate CD4 T cell proliferation in culture. However, we found that the two DC subtypes were equally potent at activating CD4 T cells, based on up-regulation of CD69 and CD25 expression. Also, we found no difference in the rate of T cell death prior to entry into the first division. We then tracked carboxyfluorescein diacetate succinimidyl ester-labeled T cells and employed a quantitative model to assess in detail the CD4 T cell expansion process in response to stimulation with CD8(+) or with CD8(-) DCs. The time required for most T cells to replicate their DNA prior to the first division was similar in both DC cultures. However, progression of the CD4 T cell population through subsequent divisions was reduced in CD8(+) DCs compared with CD8(-) DC culture. This was associated with an increased loss of viable T cells at each division. Post-activation, division-associated T cell death is therefore a major factor in the reduced response of CD4 T cells to CD8(+) DCs.
Peil J, Bock F, Kiefer F, Schmidt R, Heindl L, Cursiefen C Int J Mol Sci. 2022; 23(3).
PMID: 35163401 PMC: 8835854. DOI: 10.3390/ijms23031478.
Tullett K, Tan P, Park H, Schittenhelm R, Michael N, Li R Elife. 2020; 9.
PMID: 33264090 PMC: 7710356. DOI: 10.7554/eLife.63452.
Regulatory T Cells Suppress Effector T Cell Proliferation by Limiting Division Destiny.
Dowling M, Kan A, Heinzel S, Marchingo J, Hodgkin P, Hawkins E Front Immunol. 2018; 9:2461.
PMID: 30425712 PMC: 6218578. DOI: 10.3389/fimmu.2018.02461.
Specificity, Privacy, and Degeneracy in the CD4 T Cell Receptor Repertoire Following Immunization.
Sun Y, Best K, Cinelli M, Heather J, Reich-Zeliger S, Shifrut E Front Immunol. 2017; 8:430.
PMID: 28450864 PMC: 5390035. DOI: 10.3389/fimmu.2017.00430.
Dendritic cell control of tolerogenic responses.
Manicassamy S, Pulendran B Immunol Rev. 2011; 241(1):206-27.
PMID: 21488899 PMC: 3094730. DOI: 10.1111/j.1600-065X.2011.01015.x.